PHASE I II CLINICAL-TRIAL OF EPIRUBICIN AND PACLITAXEL FOLLOWED BY GRANULOCYTE-COLONY-STIMULATING FACTOR IN A 2-WEEK SCHEDULE IN PATIENTS WITH ADVANCED OR METASTATIC BREAST-CANCER/
F. Ries et al., PHASE I II CLINICAL-TRIAL OF EPIRUBICIN AND PACLITAXEL FOLLOWED BY GRANULOCYTE-COLONY-STIMULATING FACTOR IN A 2-WEEK SCHEDULE IN PATIENTS WITH ADVANCED OR METASTATIC BREAST-CANCER/, Seminars in oncology, 24(5), 1997, pp. 48-51